The Research and Development Team at Purespring Therapeutics is dedicated to advancing AAV gene therapy solutions for kidney diseases. This multidisciplinary team collaborates to design and optimize therapeutic candidates, develop robust bioprocessing and analytical methods, and ensure the quality and efficacy of the therapies through rigorous testing and validation. Their innovative efforts aim to translate scientific discoveries into effective treatments for patients globally.
View all